Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

Noninvasive Fetal Sex Determination Performed in Just 8 to 10 Weeks of Pregnancy

By LabMedica International staff writers
Posted on 04 Jan 2010
A simple blood test may soon become available that reveals the sex of an unborn baby.

This is the conclusion of researchers, from the University of Amsterdam (The Netherlands), who published their study in the January 2010 issue of the journal Obstetrics and Gynecology. The researchers' goal was to determine the diagnostic accuracy of noninvasive fetal sex determination in maternal plasma. More...
Real-time polymerase chain reaction (PCR) was performed for the SRY gene and multicopy DYS14 marker sequence. Between 2003 and 2009, they tested women who were between 8 and 10 weeks pregnant, examining DNA from their blood samples to predict the sex of the babies in 186 pregnancies. They predicted 105 boys and 81 girls. They were correct every time.

This appears to be good news for parents. Determining the sex of an unborn baby can lead to early detection of specific disorders. Genetic diseases such as hemophilia and Duchenne muscular dystrophy are carried by the X chromosome that usually occurs in males.

Critics, however, warn this is similar to opening Pandora's box as fetal testing evolves. Parents might not always appreciate what they discover. However, critics may be too late to stop the technology from progressing.

The researchers, however, concluded in their study that noninvasive fetal sex determination in maternal plasma is highly effective and clinically applicable.

Related Links:

University of Amsterdam




Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Collection and Transport System
PurSafe Plus®
Automatic CLIA Analyzer
Shine i9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.